R1	Has_qualifier Arg1:T1 Arg2:T2	
*	OR T4 T5
R3	AND Arg1:T6 Arg2:T4	
*	OR T10 T9
R4	Has_qualifier Arg1:T8 Arg2:T10	
R2	Has_negation Arg1:T8 Arg2:T13	
R5	AND Arg1:T6 Arg2:T8	
*	OR T1 T6
R6	Has_negation Arg1:T15 Arg2:T16	
R7	Has_qualifier Arg1:T14 Arg2:T17	
R8	Has_temporal Arg1:T19 Arg2:T20	
R9	Has_temporal Arg1:T21 Arg2:T22	
R10	AND Arg1:T21 Arg2:T19	
R11	Has_temporal Arg1:T23 Arg2:T24	
R12	Has_temporal Arg1:T25 Arg2:T26	
R13	AND Arg1:T25 Arg2:T23	
*	OR T33 T34
*	OR T27 T28 T29
R14	Has_temporal Arg1:T27 Arg2:T30	
R15	Has_mood Arg1:T27 Arg2:T32	
R16	Has_temporal Arg1:T32 Arg2:T33	
*	OR T39 T38 T40
R17	AND Arg1:T37 Arg2:T39	
R18	AND Arg1:T47 Arg2:T48	
R19	Has_qualifier Arg1:T46 Arg2:T47	
*	OR T44 T46 T45
R20	Has_temporal Arg1:T46 Arg2:T49	
R21	Has_qualifier Arg1:T52 Arg2:T51	
*	OR T56 T55
R22	Has_context Arg1:T56 Arg2:T57	
R23	Has_temporal Arg1:T56 Arg2:T58	
R24	Has_index Arg1:T60 Arg2:T61	
R25	Has_qualifier Arg1:T62 Arg2:T63	
R26	Has_temporal Arg1:T62 Arg2:T60	
R27	Has_index Arg1:T30 Arg2:T31	
T1	Condition 29 41	skin disease
T2	Qualifier 17 28	significant
T3	Temporal 0 7	History
T4	Condition 69 85	allergic illness
T5	Condition 95 117	dermatologic condition
T6	Condition 46 65	skin manifestations
T8	Condition 153 170	atopic dermatitis
T9	Qualifier 146 152	severe
T10	Qualifier 126 142	chronic moderate
T12	Subjective_judgement 177 299	would interfere with the trial assessments or compromise the patient's safety according to the opinion of the Investigator
T13	Negation 119 125	except
T14	Condition 327 340	skin diseases
T15	Condition 349 374	chronic atopic dermatitis
T16	Negation 342 348	except
T17	Qualifier 381 442	could disturb the study assessment and evaluation of the skin
T18	Undefined_semantics 381 442	could disturb the study assessment and evaluation of the skin
T19	Condition 494 519	chronic atopic dermatitis
T20	Temporal 520 536	within one month
T21	Drug 470 489	systemic medication
T22	Temporal 463 469	active
T23	Condition 619 644	chronic atopic dermatitis
T24	Temporal 645 661	within two weeks
T25	Drug 560 578	topical medication
T26	Temporal 553 559	active
T27	Observation 676 689	sunny holiday
T28	Procedure 691 707	UV-light therapy
T29	Observation 711 723	solarium use
T30	Temporal 724 777	within one month before beginning of study treatments
T31	Reference_point 748 777	beginning of study treatments
T32	Mood 782 790	planning
T33	Temporal 796 812	during the study
T34	Temporal 816 845	within 7 days after the study
T37	Condition 847 854	Allergy
T38	Drug 940 958	ProtopicÂ® ointment
T39	Drug 858 865	cis-UCA
T40	Drug 894 916	placebo emulsion cream
T42	Condition 975 994	skin-related cancer
T43	Temporal 960 967	History
T44	Condition 1010 1035	acquired immunodeficiency
T45	Condition 1019 1035;996 1006	immunodeficiency Congenital
T46	Procedure 1047 1083	therapy that cause immunosuppression
T47	Qualifier 1055 1083	that cause immunosuppression
T48	Condition 1066 1083	immunosuppression
T49	Temporal 1039 1046	ongoing
T50	Non-query-able 1085 1149	Earlier participation in a clinical study performed with cis-UCA
T51	Qualifier 1155 1177	clinically significant
T52	Procedure 1178 1193	laboratory test
T53	Undefined_semantics 1151 1200	Any clinically significant laboratory test result
T54	Subjective_judgement 1151 1200	Any clinically significant laboratory test result
T55	Condition 1228 1241	alcohol abuse
T56	Condition 1220 1224;1236 1241	drug abuse
T57	Observation 1202 1211	Suspected
T58	Temporal 1212 1219	current
T60	Temporal 1274 1331	during the 4 weeks prior to the first dose administration
T61	Reference_point 1302 1331	the first dose administration
T62	Condition 1266 1273	illness
T63	Qualifier 1243 1265	Clinically significant
T64	Subjective_judgement 1243 1331	Clinically significant illness during the 4 weeks prior to the first dose administration
T65	Post-eligibility 1333 1495	Any other condition that in the opinion of the Investigator would interfere with the evaluation of the study results or constitute a health hazard for the patient
T66	Post-eligibility 1497 1559	Unwillingness or doubtful capacity to comply with the protocol
T67	Post-eligibility 1561 1604	Doubtful availability to complete the study
